Low level of plasminogen increases risk for mortality in COVID-19 patients
Abstract The pathophysiology of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and especially of its complications is still not fully understood. In fact, a very high number of patients with COVID-19 die because of thromboembolic causes....
Main Authors: | David Della-Morte, Francesca Pacifici, Camillo Ricordi, Renato Massoud, Valentina Rovella, Stefania Proietti, Mariannina Iozzo, Davide Lauro, Sergio Bernardini, Stefano Bonassi, Nicola Di Daniele |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-08-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-021-04070-3 |
Similar Items
-
Polyphenols and Ischemic Stroke: Insight into One of the Best Strategies for Prevention and Treatment
by: Francesca Pacifici, et al.
Published: (2021-06-01) -
Glucagon Like Peptide 1 and MicroRNA in Metabolic Diseases: Focusing on GLP1 Action on miRNAs
by: Barbara Capuani, et al.
Published: (2018-12-01) -
Dietary and Protective Factors to Halt or Mitigate Progression of Autoimmunity, COVID-19 and Its Associated Metabolic Diseases
by: Camillo Ricordi, et al.
Published: (2021-03-01) -
The Impact of Vegan Diet in the Prevention and Treatment of Type 2 Diabetes: A Systematic Review
by: Daniela Pollakova, et al.
Published: (2021-06-01) -
Insulin and Exendin-4 Reduced Mutated Huntingtin Accumulation in Neuronal Cells
by: Silvia Rea, et al.
Published: (2020-05-01)